Stage III Ovarian Cancer AJCC v6 and v7 Completed Phase 0 Trials for Propranolol (DB00571)

IndicationStatusPhase
DBCOND0093245 (Stage III Ovarian Cancer AJCC v6 and v7)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01504126Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerTreatment